"Nafoxidine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An estrogen antagonist that has been used in the treatment of breast cancer.
| Descriptor ID |
D009256
|
| MeSH Number(s) |
D03.383.773.589
|
| Concept/Terms |
U-11,100A- U-11,100A
- U 11,100A
- U11,100A
- U-11000A
- U 11000A
- U11000A
|
Below are MeSH descriptors whose meaning is more general than "Nafoxidine".
Below are MeSH descriptors whose meaning is more specific than "Nafoxidine".
This graph shows the total number of publications written about "Nafoxidine" by people in this website by year, and whether "Nafoxidine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Nafoxidine" by people in Profiles.
-
Triphenylethylene antiestrogens induce uterine vascular endothelial growth factor expression via their partial estrogen agonist activity. Cancer Lett. 1997 Dec 09; 120(2):165-71.
-
Transcriptional activation by the estrogen receptor requires a conformational change in the ligand binding domain. Mol Endocrinol. 1993 Oct; 7(10):1266-74.
-
Identification of a negative regulatory function for steroid receptors. Proc Natl Acad Sci U S A. 1992 Nov 15; 89(22):10563-7.
-
Ligand-dependent and -independent function of the transactivation regions of the human estrogen receptor in yeast. Mol Endocrinol. 1992 Jul; 6(7):1043-50.
-
In vitro analysis of the cellular proliferative response to 17-beta-estradiol of human breast cancer. Cancer. 1988 May 01; 61(9):1807-12.
-
Human breast cancer cell cycle synchronization by estrogens and antiestrogens in culture. Cancer Res. 1984 Apr; 44(4):1433-9.
-
Stimulatory and inhibitory effects of estrogen and antiestrogen on uterine cell division. Endocrinology. 1981 Oct; 109(4):1005-10.
-
Selective blockade of estrogen-induced uterine responses by the antiestrogen nafoxidine. Endocrinology. 1978 Nov; 103(5):1583-9.
-
Receptors and breast cancer: do we know it all? J Steroid Biochem. 1978 May; 9(5):461-6.
-
Effect of the anti-estrogen, Nafoxidine, on NZB/W autoimmune disease. Arthritis Rheum. 1978 May; 21(4):414-7.